We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

Results: 2

1.
Figure 1:

Figure 1:. From: Cost-effectiveness of Breast MR Imaging and Screen-Film Mammography for Screening BRCA1 Gene Mutation Carriers1.

Cumulative breast cancer mortality according to screening strategy. Ann Mammo = annual screen-film mammography, Ann MRI = annual MR imaging, Ann Combined = annual combined screening.

Janie M. Lee, et al. Radiology. 2010 March;254(3):793-800.
2.
Figure 2:

Figure 2:. From: Cost-effectiveness of Breast MR Imaging and Screen-Film Mammography for Screening BRCA1 Gene Mutation Carriers1.

Sensitivity analysis of diagnostic test performance. ICER for annual combined screening remained within range of $50000–$100000 per QALY for most sensitivity and specificity pairs examined, until the sensitivity of combined mammography and MR imaging screening declined below 76%. Base case = Leach et al (13), Peters = Peters et al (30), Kuhl = Kuhl et al (17), Warner = Warner et al (15).

Janie M. Lee, et al. Radiology. 2010 March;254(3):793-800.

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Write to the Help Desk